Table 1 Summary of the demographic and baseline characteristics.
From: Neuronal apoptosis inhibitory protein is implicated in amyotrophic lateral sclerosis symptoms
ALS (n = 18) | Control (n = 12) | |
|---|---|---|
age, year (SD) | 64.1 (12.3) | 59.8 (11.9) |
male/female, n | 13/5 | 4/8 |
clinical onset, n (%) | ||
bulbar | 6 (33.3) | |
upper limb | 9 (50.0) | |
lower limb | 3 (16.7) | |
duration months (SD) | 27.6 (16.3) | |
ALSFRS-R score | 37.1 (7.4) | |
forced vital capacity, % (SD) | 77.3 (27.5) | |
riluzole, n (%) | 18 (100) | |
PEG, n (%) | 11 (61.1) | |
NIV, n (%) | 7 (38.9) |
